Culturing of human umbilical cord mesenchymal stem cells via a 3D suspension culture system using the microcarrier
Received date: 2018-06-15
Revised date: 2018-09-03
Online published: 2018-09-04
Supported by
Supported by the Key Deployment Projects of CAS (No. ZDRW-ZS-2016-2)
With the rapid development of stem cell research, the demands for high quality stem cells in cell differentiation studies, cell therapy and clinical applications increase significantly. Human umbilical cord mesenchymal stem cells (hUCMSCs) hold great potentials in these applications due to its wide availability, self-renewal capacity, good pluripotency, and in particular, self-immunomodulation ability. However, the conventional adherent culture system remains challenging in mass production of high-quality stem cells. In this study, we set up a 3D suspension culture system by using spinner flasks added with microcarrier. By optimizing the seeding density and rotation speed, we achieved a cell density as higher as 7×10 8cells/L per vessel. The cultured MSCs had good viability, and the expression levels of the MSC markers were similar to those of 2D-cultured MSCs. After being transferred back into a 2D culture system, the MSCs still maintained normal morphology and proliferation ability. These results indicated that the 3D suspension culture system established in this study provides a fundamental basis for mass production of high-quality MSCs for future research and clinical applications.
Xia Li, Huijuan Hua, Jie Hao, Liu Wang, Zhonghua Liu . Culturing of human umbilical cord mesenchymal stem cells via a 3D suspension culture system using the microcarrier[J]. Hereditas(Beijing), 2018 , 40(12) : 1120 -1128 . DOI: 10.16288/j.yczz.18-123
| [1] | Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC, Chen YC . Isolation of multipotent cells from human term placenta. Stem Cells, 2005,23(1):3-9. | |||
| [2] | Kern S, Eichler H, Stoeve J, Klüter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 2006,24(5):1294-1301. | |||
| [3] | Yang XF, He X, He J, Zhang LH, Su XJ, Dong ZY, Xu YJ, Li Y, Li YL . High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells. J Biomed Sci, 2011,18(1):59. | |||
| [4] | Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH . Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood, 2004,103(5):1669-1675. | |||
| [5] | Romanov YA, Svintsitskaya VA, Smirnov VN . Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cell, 2003,21(1):105-110. | |||
| [6] | Caplan AI . Mesenchymal stem cells. J Orthop Res, 1991,9(5):641-650. | |||
| [7] | Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, Goda M, Akashi H, Inutsuka A, Niwa A, Shigemoto T, Nabeshima Y, Nakahata T, Nabeshima Y, Fujiyoshi Y, Dezawa M . Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA, 2010,107(19):8639-8643. | |||
| [8] | Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O . HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol, 2003,31(10):890-896. | |||
| [9] | Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ , McIntosh KR.T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci, 2005,12(1):47-57. | |||
| [10] | Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, Weinberg RA . Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell, 2011,145(6):926-940. | |||
| [11] | Otto WR, Wright NA . Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair, 2011,4(1):20. | |||
| [12] | Caplan AI, Correa D . The MSC: an injury drugstore. Cell Stem Cell, 2011,9(1):11-15. | |||
| [13] | Aggarwal S, Pittenger MF . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005,105(4):1815-1822. | |||
| [14] | Ohno T, Kaneda H, Nagai Y, Fukushima M . Regenerative medicine in critical limb ischemia. J Atheroscler Thromb, 2012,19(10):883-889. | |||
| [15] | Zhao Y, Tang F, Xiao Z, Han G, Wang N,
/
|